Mylan has become the first company to launch a generic version of GlaxoSmithKline's (GSK) big-selling respiratory drug Seretide in the UK. Seretide (salmeterol xinafoate/fluticasone propionate ...

It doesn’t come in a generic version. However, there are other different inhaled versions of the active ingredient found in Spiriva that are available as a generic. A generic drug is an exact ...

Drug companies are taking advantage of a global climate treaty to boost profits. The treaty, signed by some 120 countries nearly a decade ago, is now providing inhaler makers with a golden escape ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

at § 355(b)(1)(A)(viii). Teva’s Inhaler Patents relate generally to an inhaler device for delivering the drug. More specifically, the patents claim metered dose inhaler dose counters ...

The inhalation and nasal spray generic drugs market has experienced robust growth in recent years, expanding from $28.01 billion in 2023 to $30.06 billion in 2024 at a compound annual growth rate ...

Purpose: The effects of extreme temperatures on drug delivery of two albuterol sulfate hydrofluoroalkane, metered-dose inhalers (MDIs) were evaluated.Methods. Three Proventil HFA and three ...

Many people manage the disease using injections or pumps, but a new study that was conducted in part by the Mayo Clinic highlights another option for patients: an insulin inhaler. “I feel a lot ...

Inhaler have announced details of a huge UK and European tour to take place in the first half of 2025 – check out all the dates below. READ MORE: Inhaler tell us about single ‘Your House ...

Drug delivery describes the method and approach ... The instability of lipid nanoparticles during nebulization hinders inhaled mRNA vaccines. Here, the authors report on a charge-assisted ...

U.S. researchers have detected microplastic particles in air exhaled by wild bottlenose dolphins, suggesting that inhalation may be a relevant route of exposure to these potentially harmful ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...